Showing results (151-160 of 168) with videos related to

Sort By:
Pageof 17
European Journal of Preventive Cardiology|April 5, 2011
Prescribing high-dose lipid-lowering therapy early to avoid subsequent cardiovascular events: is this a cost-effective strategy?R Ara, A Pandor, J Stevens, et al.
Diabetologia|November 15, 2005
Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS)H M Colhoun, D J Betteridge, P N Durrington, et al.
Atherosclerosis|May 12, 2018
Coronary heart disease mortality in treated familial hypercholesterolaemia: Update of the UK Simon Broome FH registerS E Humphries, J A Cooper, M Seed, et al.
Atherosclerosis|April 2, 2010
All-cause and cardiovascular mortality in treated patients with severe hypertriglyceridaemia: A long-term prospective registry studyH A W Neil, J Cooper, D J Betteridge, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|June 1, 2007
GST CYP and PON1 polymorphisms in farmers attributing ill health to organophosphate-containing sheep dipA C Povey, F Jury, W M Dippnall, et al.
BMJ (Clinical Research Ed.)|May 23, 1992
Treatment of familial hypercholesterolaemia. United Kingdom lipid clinics study of pravastatin and cholestyramineD J Betteridge, D Bhatnager, R F Bing, et al.
Diabetologia|February 1, 2007
Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS)M Raikou, A McGuire, H M Colhoun, et al.
Postgraduate Medical Journal|May 1, 1993
Management of hyperlipidaemia: guidelines of the British Hyperlipidaemia AssociationD J Betteridge, P M Dodson, P N Durrington, et al.
The American Journal of Medicine|June 6, 1994
Comparison of lipid-lowering effects of low-dose fluvastatin and conventional-dose gemfibrozil in patients with primary hypercholesterolemiaD J Betteridge, P N Durrington, G J Fairhurst, et al.
Heart (British Cardiac Society)|November 18, 2004
Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemiaH A W Neil, V Seagroatt, D J Betteridge, et al.
Pageof 17